AHI (Anastrozole 1 mg)

Pill imprint AHI has been identified as Anastrozole 1 mg.

Anastrozole is used in the treatment of breast cancer, metastatic; breast cancer; pubertal gynecomastia; mccune-albright syndrome; endometrial cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Anastrozole 1 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for AHI

Anastrozole 1 mg AHI
Anastrozole
Imprint:
AHI
Strength:
1 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Aromatase inhibitors
Hormones/antineoplastics
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Accord Healthcare
National Drug Code (NDC):
16729-0035
Inactive Ingredients:
lactose
magnesium stearate
hypromelloses
polyethylene glycol
povidone
sodium starch glycolate type A potato
titanium dioxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)